Publications 2003

Andersen K, Smith-Sorensen B, Pedersen KB, Hovig E, Myklebost O, Fodstad O, Maelandsmo GM (2003) Interferon-gamma suppresses S100A4 transcription independently of apoptosis or cell cycle arrest. Br J Cancer. 88:1995-2001.

Henriksen J, Aagesen T, Maelandsmo GM, Lothe RA, Myklebost O, Forus A (2003) Amplification and overexpression of COPS3potentially target TP53 for proteasome-mediated degradation. Oncogene 22:5358-61

Maire G, Forus A, Foa C, Bjerkehagen B, Mainguené C, Henrichson-Kresse S, Myklebost O, Florence Pedeutour F (2003) 11q13 alterations in two cases of hibernoma : large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes Cancer 37:389–395.

Nygaard V, Loland A, Holden M, Langaas M, Rue H, Liu F, Myklebost O, Fodstad Ř, Hovig E, Smith-Sorensen B (2003) Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance BMC Genomics 4:11

Smeland S, Müller C, Alvegard TA, Wiklund T, Wiebe T, Bjork O, Stenwig AE, Willen H, Holmstrom T, Folleras G, Brosjo O, Kivioja A, Jonsson K, Monge O, Saeter G (2003) Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer 39: 488-494.

Skomedal H, Forus A, Holm R (2003) Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer. Anticancer Res 23:3929-35

Wang J, Myklebost O, Hovig E (2003) MGraph: graphical models for microarray data analysis. Bioinformatics 19:2210-2211

Wang J, Bř TH, Jonassen I, Myklebost O, Hovig E (2003). Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data BMC Bioinformatics 4:60